InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
50%
T+90 mean return
+27.2%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Watson Daniel Copell, Vice-Président Exécutif des ventes Amériques. Officer active across 1 company, notably Beauty Health Co. In total, 13 filings have been logged. History available since 20 May 2021. The latest transaction was filed on 4 February 2023 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
8,972 shares@ US$12.90100.0% of flowClass A Common StockSEC:0001628280-24-027739:0
243,506 sharesClass A Common StockSEC:0001628280-24-015847:0
156,250 sharesClass A Common StockSEC:0001628280-23-040452:0
94,265 sharesClass A Common StockSEC:0001628280-23-011059:0
17,560 sharesClass A Common StockSEC:0001818093-23-000010:0
77,835 sharesClass A Common StockSEC:0001818093-22-000023
77,835 sharesClass A Common StockSEC:0001818093-22-000023:0
363 shares0Class A Common StockSEC:0001818093-21-000041
363 shares0Class A Common StockSEC:0001818093-21-000041:0
38,429 shares0Class A Common StockSEC:0001818093-21-000027:0
38,429 shares0Class A Common StockSEC:0001818093-21-000027
178,569 shares0Class A Common StockSEC:0001818093-21-000012
178,569 shares0Class A Common StockSEC:0001818093-21-000012:0
13 of 13 declarations
About Watson Daniel Copell
Daniel Copell Watson is the Executive VP Americas Sales at Beauty Health Co. In this role, he oversees the sales and marketing operations of the company in the Americas. His experience is crucial in developing the company's business strategy.
